References
- CMS Manual System. Pub 100-03 Medicare National Coverage
Determinations. National Coverage Determination (NCD20.8.4): Leadless
Pacemakers. Department of Health & Human Services, Centers for
Medicare & Medicaid Services.
- Piccini JP, El-Chami M, Wherry K, Crossley GH, Kowal RC, Stromberg K,
Longacre C, Hinnenthal J, Bockstedt L. Contemporaneous Comparison of
Outcomes Among Patients Implanted With a Leadless vs Transvenous
Single-Chamber Ventricular Pacemaker. JAMA
Cardiol. 2021;6(10):1187-1195. doi:10.1001/jamacardio.2021.2621
- El-Chami M, Bockstedt L, Longacre C, Higuera L, Stromberg K, Crossley
G, Kowal RC, Piccini JP. Leadless vs. transvenous single-chamber
ventricular pacing in the Micra CED Study: 2-year follow-up. European
Heart Journal 2022; 43: 1207-1215.
https://doi.org/10.1093/eurheartj/ehab767.
- Duray GZ, Ritter P, El-Chami M et al.; Micra Transcatheter Pacing
Study Group. Long-term performance of a transcatheter pacing system:
12-month results from the Micra transcatheter pacing study. Heart
Rhythm 2017;14:702–709.
- El-Chami MF, Al-Samadi F, Clementy N et al. Updated performance of the
Micra transcatheter pacemaker in the real-world setting: a comparison
to the investigational study and a transvenous historical control.
Heart Rhythm 2018;15: 1800–1807.
- Wherry K, Stromberg K, Hinnenthal JA, Wallenfelsz LA, El-Chami MF,
Bockstedt L. Using Medicare Claims to Identify Acute Clinical Events
Following Implantation of Leadless Pacemakers. Pragmat Obs Res
2020;11:19-26.
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of
classifying prognostic comorbidity in longitudinal studies:
development and validation. J Chronic Dis 1987;40:373–383.
- Anker SD, Schroeder S, Atar D et al. Traditional and new composite
endpoints in heart failure clinical rials: facilitating comprehensive
efficacy assessments and improvement trial efficiency. European
Journal of Heart Failure 2016; 18(5): 482-489.
- Li F, Thomas LE, Li F. Addressing extreme propensity scores via the
overlap weights. Am J Epidemiol 2019;188:250–257.
- Li F, Morgan KL, Zaslavsky AM. Balancing covariates via propensity
score weighting. J Am Stat Assoc 2018;113:390–400.
- Kucharska-Newton AM, Heiss G, Ni H et al. Identification of heart
failure events in Medicare claims: the Atherosclerosis Risk in
Communities (ARIC) study. J Card Fail 2016;22:48–55.
- Sanchez R, Nadkarni A, Buck B et al. Incidence of pacing-induced
cardiomyopathy in pacemaker-dependent patients is lower with leadless
pacemakers compared to transvenous pacemakers. J Cardiovasc
Electrophysiol 2021; 32:477-483.
- Wilkoff BL, Boriani G, Mittal S et al. Impact of Cardiac Implantable
Electronic Device Infection: A Clinical and Econonic Analysis of the
WRAP-IT Trial. Circulation AE 2020; 13(5).
https://doi.org/10.1161/CIRCEP.119.008280.
- El-Chami M, Piccini JP, Bockstedt L. In Reply: Leadless Pacing –
Uncertainties Remain About Safety and Efficacy. JAMA Cardiology.
Published Online: January 26, 2022. doi:10.1001/jamacardio.2021.5713.